Technology [ 9/13 ] | Information Technology Services [ 103/164 ]
NYSE | Common Stock
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific.
It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property.
The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets.
In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement.
It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations.
The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020.
Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 8, 24 | 0.14 Decreased by -22.22% | 0.14 |
| Feb 27, 24 | 0.23 Increased by +4.55% | 0.21 Increased by +9.52% |
| Nov 7, 23 | 0.21 Increased by +5.00% | 0.18 Increased by +16.67% |
| Aug 3, 23 | 0.21 Decreased by -4.55% | 0.20 Increased by +5.00% |
| May 9, 23 | 0.18 Decreased by -14.29% | 0.15 Increased by +20.00% |
| Mar 1, 23 | 0.22 Decreased by -4.35% | 0.17 Increased by +29.41% |
| Nov 8, 22 | 0.20 Increased by +25.00% | 0.18 Increased by +11.11% |
| Aug 9, 22 | 0.22 Increased by +29.41% | 0.21 Increased by +4.76% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | 621.20 M Decreased by -1.26% | -75.00 M Decreased by -272.41% | Decreased by -12.07% Decreased by -274.61% |
| Dec 31, 23 | 683.70 M Increased by +2.23% | -843.90 M Decreased by -585.54% | Decreased by -123.43% Decreased by -570.60% |
| Sep 30, 23 | 647.20 M Increased by +2.88% | 12.30 M Decreased by -71.72% | Increased by +1.90% Decreased by -72.51% |
| Jun 30, 23 | 668.80 M Decreased by -2.59% | -123.10 M Decreased by -297.28% | Decreased by -18.41% Decreased by -302.53% |
| Mar 31, 23 | 629.10 M Decreased by -5.00% | 43.50 M Decreased by -37.41% | Increased by +6.91% Decreased by -34.12% |
| Dec 31, 22 | 668.80 M Increased by +19.28% | -123.10 M Decreased by -10.55% | Decreased by -18.41% Increased by +7.32% |
| Sep 30, 22 | 629.10 M Increased by +42.29% | 43.50 M Increased by +86.60% | Increased by +6.91% Increased by +31.14% |
| Jun 30, 22 | 686.60 M Increased by +54.07% | 62.40 M Increased by +175.90% | Increased by +9.09% Increased by +149.27% |